Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen To Use BioProcessors SimCell in PD-Direct Services Offering

NEW YORK, June 20 (GenomeWeb News) - Invitrogen said today that it will add the SimCell robotic system from BioProcessors to its process development services offering.

 

Under the terms of the technology collaboration agreement, Invitrogen is installing a SimCell unit in its Grand Island, NY, facility.

 

Invitrogen's PD-Direct clients will have access to BioProcessors' high throughput simulated scale-down bioreactor tool beginning this fall. PD-Direct handles manufacturing scale-up, quality testing, and cell line optimization functions for biotechnology and pharmaceutical companies.

 

The companies will collaborate on the development of high-throughout cell culture applications for the SimCell platform and will expand microbioreactor technology for use in other areas, Invitrogen said.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.